You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Figure PDU-6:  National and sub-national estimates of the prevalence of problem drug use (rate per 1000 population aged 15 to 64), 2000 to 2004 – Part (ii) Opioids use prevalence

Figure PDU-06 part ii

Notes:

Black square = samples with national coverage; blue triangle = samples with sub-national coverage

Target groups may vary slightly owing to different methods and data sources; therefore comparisons should be made with caution. For more details see Table PDU-1 to Table PDU-3.

The pattern of sub-national prevalence estimates depends much on availability and location of studies, however, if available, sub-national estimates can suggest that prevalence is different from the national average in specific cities or regions. The estimates of Czech Republic refer to the age group 18-64.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

National Focal Points. See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich (http://www.emcdda.europa.eu/?nnodeid=1372).